Starting Your Research the Right Way
If you're looking into medical weight management, you've probably come across terms like GLP-1 and GIP, along with medication names such as semaglutide and tirzepatide. These are two distinct classes of prescription medication that work on appetite and metabolism through different receptor pathways, and they're often discussed together because they're used in similar clinical contexts.
Before requesting a consultation, it helps to understand what these medications are, what the current evidence generally shows, and what questions are worth bringing to a clinician. This guide won't tell you whether either option is right for you — that depends on individual review — but it should help you ask better questions and know what to expect.
Understanding the Medication Classes
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GLP-1 and GIP receptors, which is why it's sometimes called a dual-agonist. Both are used in a supervised medical weight-management context, but they aren't interchangeable, and the decision between them (if either is discussed at all) is a clinical one based on health history, current medications, and individual goals.
Common questions people bring to us include: How do these medications affect appetite and digestion? What side effects come up most often, and how are they typically managed? How long is a program usually expected to run before reassessing progress? These are all reasonable things to raise directly in a consultation rather than trying to self-diagnose fit from general information online.
### What a Consultation and Evaluation Generally Involves
A consultation is where a clinician reviews your health history, current medications, and goals to determine whether a weight-management discussion is relevant for you. Depending on what's clinically appropriate, laboratory testing may be requested — but not every reader needs the same tests, and lab review is not required before you can ask questions or request information.
It's also useful to know that a consultation request does not create a provider-patient relationship on its own. It starts a conversation. From there, the care team follows up using the contact information you provide to answer questions and explain what next steps, if any, might make sense.
### Common Concerns Worth Raising
Many people researching this topic are already on a related treatment and are looking for clearer follow-up or a second opinion — that's a reasonable reason to reach out. Others want to understand cost or whether insurance applies before going further; those specifics should be confirmed directly with the team rather than assumed from general pricing you may see elsewhere.
If you're concerned about safety or side effects, that's exactly the kind of question a clinician can walk through with you, including what monitoring might look like and what would prompt a follow-up conversation. None of this can be answered generically — safety and suitability are individual and determined case by case, not assumed in advance.
Frequently Asked Questions
Below are common follow-up questions people ask before requesting a weight-management consultation, including how semaglutide and tirzepatide differ, what testing may involve, and what happens after you reach out.
Where to Learn More
For a deeper look at how this service category is organized, visit the Medical Weight Management service page. If you want a quick definition-style reference, the Medical Weight Management glossary entry and the Telehealth Consultation glossary entry can help you understand terminology before you reach out.
Ready to Ask Your Questions?
If you have specific questions about semaglutide, tirzepatide, or how a weight-management evaluation generally works, the most direct next step is to request a consultation through Contact Us. Someone from the team will follow up using the information you provide to help you understand what, if anything, makes sense to explore further.
Request a consultation
Request a Consultation
FAQs
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP receptors. Both are used in supervised medical weight-management contexts, but they are distinct medications, and whether either is discussed for you depends on individual clinician review.
Do I need blood work before a consultation?
Not necessarily. Laboratory testing may be requested when clinically relevant, but the same tests aren't required for every reader. You can request a consultation and ask questions before any labs are discussed.
What happens after I submit a consultation request?
The care team follows up using the contact details you provide to answer your questions and discuss possible next steps. Submitting a request does not create a provider-patient relationship on its own.
Is telehealth available for medical weight management?
Whether telehealth is offered for this program should be confirmed directly with the team, since availability can vary and isn't something we can state as a fixed fact in general educational content.
I'm already taking a weight-management medication. Can I still reach out?
Yes. Many people who contact us are already using a related treatment and are looking for another clinician's perspective or clearer follow-up. That's a reasonable reason to request a consultation.
What determines whether one of these medications is right for me?
That determination comes from an individual clinician review of your health history, current medications, and goals — not from anything you read on this page. No specific outcome or eligibility can be assumed in advance.
What should I ask about cost and insurance?
Cost and insurance details vary and should be confirmed directly with the team during your consultation request rather than assumed from general information you find elsewhere.